Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.63 No.12

Vol.63 No.12 contents

Request review

Biological phase separation in neuromuscular diseases

Noriyoshi Isozumi, Ph.D.1),Kazuma Sugie, M.D., Ph.D.2) and Eiichiro Mori, M.D., Ph.D.1)

CLINICA NEUROL, 63: 799−805, 2023

Request review

The differential diagnosis of inflammatory and non-inflammatory myelopathy

Tetsuo Ando, M.D., Ph.D.1)

CLINICA NEUROL, 63: 806−812, 2023

Original Article

Impact of migraine on family members: an investigation by Impact of Migraine on Partners and Adolescent Children (IMPAC)

Takao Takeshima, M.D., Ph.D.1), Satomi Ooba, M.D., Ph.D.2), Yoshiki Hanaoka, M.D., Ph.D.3), Masayuki Hamakawa, Ph.D.4), Yoshinori Tanizawa, Ph.D.5), Satoshi Osaga5), Hideyuki Imagawa5), Michio Okada5) and Mika Komori, M.D., Ph.D.5)

CLINICA NEUROL, 63: 813−823, 2023

Case Report

A case of acute bilateral blindness presumably caused by reversible cerebral vasoconstriction syndrome after traumatic brain injury

Yuki Fujii, M.D.1), Keiichi Hokkoku, M.D.1), Takashi Chiba, M.D.1), Kazusa Takahashi, M.D.1)4), Tatsuya Mimura, M.D.2), Hiroshi Ooba, M.D.3), Masahiro Sonoo, M.D.1)5) and Shunsuke Kobayashi, M.D.1)

CLINICA NEUROL, 63: 824−829, 2023

Case Report

A case of anti-acetylcholine receptor antibody-positive ocular myasthenia gravis with anti-titin antibody and anti-Kv1.4 antibody positive inflammatory myopathy

Kenshiro Fuse, M.D.1), Amane Araki, M.D., Ph.D.1), Saori Morozumi, M.D., Ph.D.1), Keizo Yasui, M.D., Ph.D.1), Tomoyuki Kazuta, M.D.2)3), Seiya Noda, M.D., Ph.D.2)4) and Masahisa Katsuno, M.D., Ph.D.2)5)

CLINICA NEUROL, 63: 830−835, 2023

Case Report

A case of myofibrillary myopathy due to Bcl2-Associated Athanogene 3 (BAG3) mutation complicated by peripheral neuropathy

Risa Nagatomo, M.D.1), Yujiro Higuchi, M.D., Ph.D.1), Jun Takei, M.D.1), Tomonori Nakamura, M.D., Ph.D.1), Hiroaki Hashiguchi, M.D., Ph.D.1) and Hiroshi Takashima, M.D., Ph.D.1)

CLINICA NEUROL, 63: 836−842, 2023

Brief Clinical Note

A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report

Ryoji Nakada, M.D.1), Yuka Terasawa, M.D., Ph.D.1), Takeo Sato, M.D.1), Hiroki Takatsu, M.D.1), Nobuyoshi Kaito, M.D., Ph.D.2) and Yasuyuki Iguchi, M.D., Ph.D.1)

CLINICA NEUROL, 63: 843−846, 2023

The Proceedings of the 111th Tohoku Regional Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 63: 847−852, 2023

Notice for Members

CLINICA NEUROL, 63: 853−855, 2023

Notice for Members

CLINICA NEUROL, 63: 856−860, 2023

Notice for Members

CLINICA NEUROL, 63: 861−863, 2023

Notice for Members

CLINICA NEUROL, 63: 864−865, 2023

Editor's Note

CLINICA NEUROL, 63: 866−866, 2023